Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...

(RTTNews) - Amgen (AMGN) and Kyowa Kirin Co., Ltd. announced new results from the ongoing ROCKET Phase 3 clinical trial program evaluating rocatinlimab, an investigational T-cell rebalancing ...

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...

After hours: March 12 at 7:57:00 PM EDT Loading Chart for AMGN ...

Pre-Market: 8:33:11 a.m. EDT Loading Chart for AMGN ...

1 In 2024, Dr. Kelly’s team reported the first-in-human study of Xaluritamig monotherapy dose exploration for patients with mCRPC, primarily taxane pretreated. 2 There were 97 patients that received ...

William Kelly presents the results from a Phase 1 study of xaluritamig, a bispecific T-cell engager targeting STEAP1, in patients with mCRPC. The study showed promising antitumor activity, with a 49% ...